The global market for Behçet's disease therapeutics is experiencing a period of significant growth, driven by an increasing prevalence of the disease and advancements in treatment options. The need for effective therapies to manage the varying symptoms of Behçet's disease is propelling this growth. Pharmaceutical companies are actively researchin